The epidemic has caused serious trauma to the world economy, but the medical sector related to the epidemic has been sought after by the market. Running all the way's share price, many stocks rose 2 or 3 times a year. With the gradual control of the epidemic, COVID-19 vaccine has attracted everyone's attention, and about 7 billion doses of COVID-19 vaccine have been subscribed worldwide, which has made many investors see the opportunity and think that vaccine stocks still have a lot of room for growth, but I don't quite agree with this view, because we all know the news already.
First, the vaccine unit has no chance.
Everyone should know that stock speculation is expected. When the stock price starts to rise and everyone is still in a state of doubt, this is the opportunity to buy stocks, because people with foresight make money, and those who know later pay the bill. When everyone knows the news, it's time to pay the bill. The stock market has always been like this. As you can see, the world has subscribed for about 7 billion doses of COVID-19 vaccine, and this news is worthless. Buying vaccine stocks at this time is the time to pay the bill.
Second, what is the basis for judging that the vaccine unit has no chance?
The epidemic has been brought under control, and vaccine stocks have also increased a lot. Many stocks have gone up two or three times, and many vaccine stocks simply can't get so many big vaccine orders, resulting in their share prices being overvalued. Overvaluation of the stock market is the biggest risk. Vaccine stocks have gained a lot and are highly valued. These are the reasons why I am very pessimistic.
Third, what about the high quilt cover of vaccine inventory?
Many vaccine stocks have fallen for several days, and the market has responded to the news in advance. If the quilt cover is high, you must not add more positions, otherwise it may make you very passive. You can die at this time, and then consider lightening your position after rebounding.